Clinical trial
Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy
NCT00242931 · OHSU Knight Cancer Institute, Other · Withdrawn
Key facts
| NCT number | NCT00242931 |
|---|---|
| Title | Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy |
| Official title | Pilot Trial of Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Hormone-Refractory Prostate Cancer |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Other |
| Interventions | Nonmyeloablative stem cell conditioning regimen |
| Enrollment | 0 |
| Start date | Jan 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Oct 21, 2005 |
| Last update posted | Jun 1, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: